Effects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on the incidence of breast pain

被引:0
|
作者
Boudes, P
Ronkin, S
Korner, P
Baracat, E
Constantine, G
机构
[1] Wyeth Ayerst Res, Collegeville, PA USA
[2] Univ Fed Sao Paulo, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S14 / S14
页数:1
相关论文
共 50 条
  • [21] Effects of a novel selective estrogen receptor modulator (SERM) on cell proliferation and growth in a macaque autograft model for endometriosis.
    Carroll, R.
    Kaufmann-Reiche, U.
    Schmidt, A.
    Fuhrmann, U.
    Fritzemejer, K. H.
    Slayden, O. D.
    FERTILITY AND STERILITY, 2007, 88 : S60 - S60
  • [22] Preclinical breast effects of a tissue selective estrogen complex (TSEC) including conjugated estrogen with bazedoxifene
    Santen, Richard J.
    Song, Yan
    Wang, Ji-ping
    Yue, Wei
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 170 : 61 - 64
  • [23] Chemopreventive effects of selective estrogen receptor modulator (SERM) raloxifene on intestinal neoplasia of APCMin/+ mice
    Janakiram, Naveena B.
    Mohammed, Altaf
    Qian, Li
    Venkateshwar, Madka
    Reddy, Manasa P.
    Steele, Vernon E.
    Rao, Chinthalapally V.
    CANCER RESEARCH, 2011, 71
  • [24] MECHANISMS INVOLVED IN THE NEUROPROTECTIVE EFFECTS OF THE SELECTIVE ESTROGEN RECEPTOR MODULATOR, BAZEDOXIFENE, IN ACUTE ISCHEMIC STROKE
    Jover-Mengual, T.
    Castello-Ruiz, M.
    Torregrosa, G.
    Burguete, M. C.
    Lopez-Morales, M. A.
    Jurado-Rodriguez, A.
    Aliena, A.
    Jorques, M.
    Alborch, E.
    Salom, J. B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 21 - 21
  • [25] Idoxifene, a novel selective estrogen receptor modulator (SERM), preserves endothelial function after ischemia and reperfusion
    Ma, XL
    Chen, J
    Lopez, BS
    Christopher, TA
    Ohlstein, EH
    Yue, TL
    CIRCULATION, 1999, 100 (18) : 220 - 220
  • [26] Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women
    Archer, David F.
    Pinkerton, JoAnn V.
    Utian, Wulf H.
    Menegoci, Jose C.
    de Villiers, Tobie J.
    Yuen, Chui Kin
    Levine, Amy B.
    Chines, Arkadi A.
    Constantine, Ginger D.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (06): : 1109 - 1115
  • [27] Targeting Fatty Acid Synthase (FASN) in breast and endometrial cancer: An alternative to Selective Estrogen Receptor Modulator (SERM)
    Lupu, R.
    Menendez, J.
    DIFFERENTIATION, 2006, 74 (08) : 458 - 458
  • [28] Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women (vol 105, pg 1397, 2005)
    Ronkin, S
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (04): : 869 - 869
  • [29] Carcinogenicity and Hormone Studies with the Tissue-Selective Estrogen Receptor Modulator Bazedoxifene (vol 228, pg 724, 2013)
    Wright, David J.
    Earnhardt, J. Nicole
    Perry, Richard
    Bailey, Steven
    Komm, Barry
    Minck, Daniel R.
    Cukierski, Mark A.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (01) : 126 - 126
  • [30] Comparison of ERA-923, a new selective estrogen receptor modulator (SERM) for the treatment of estrogen-receptor positive breast cancer, with other SERMs.
    Greenberger, LM
    Komm, B
    Miller, C
    Annable, T
    Lyttle, R
    Frost, P
    CLINICAL CANCER RESEARCH, 2000, 6 : 4565S - 4565S